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The Initiation Factors eIF2, eIF2A,
eIF2D, eIF4A, and eIF4G Are Not
Involved in Translation Driven by
Hepatitis C Virus IRES in Human
Cells
Esther González-Almela, Hugh Williams, Miguel A. Sanz and Luis Carrasco*
Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain
Animal viruses have evolved a variety of strategies to ensure the efficient translation
of their mRNAs. One such strategy is the use of internal ribosome entry site (IRES)
elements, which circumvent the requirement for some eukaryotic initiation factors (eIFs).
Much effort has been directed to unravel the precise mechanism of translation initiation
by hepatitis C virus (HCV) mRNA. In the present study, we examined the involvement
of several eIFs in HCV IRES-driven translation in human cells in a comparative analysis
with mRNAs bearing the encephalomyocarditis virus or the Cricket paralysis virus IRES
element. Consistent with previous findings, several inhibitors of eIF2 activity, including
sodium arsenite, thapsigargin, tunicamycin, and salubrinal, had no inhibitory effect on
the translation of an mRNA bearing the HCV IRES, and all induced the phosphorylation
of eIF2α. In addition, hippuristanol and pateamine A, two known inhibitors of eIF4A,
failed to block HCV IRES-directed translation. To test the release of nuclear proteins to
the cytoplasm and to analyze the formation of stress granules, the location of the nuclear
protein TIA1 was tested by immunocytochemistry. Both arsenite and pateamine A could
efficiently induce the formation of stress granules containing TIA1 and eIF4G, whereas
eIF3 and eIF2 failed to localize to these cytoplasmic bodies. The finding of eIF4A and
eIF4G in stress granules suggests that they do not participate in mRNA translation.
Human HAP1 cells depleted for eIF2A, eIF2D, or both factors, were able to synthesize
luciferase from an mRNA bearing the HCV IRES even when eIF2α was phosphorylated.
Overall, these results demonstrate that neither eIF2A nor eIF2D does not participate in
the translation directed by HCV IRES. We conclude that eIF2, eIF4A, eIF2A, and eIF2D
do not participate in the initiation of translation of HCV mRNA.
Keywords: regulation of protein synthesis, initiation factor of translation, inhibitors of eIF2, regulation of viral
translation, eIF2 phosphorylation
INTRODUCTION
Hepatitis C virus (HCV) is responsible for the vast majority of chronic viral hepatitis and induces
hepatocarcinoma in humans (Hajarizadeh et al., 2013; Khullar and Firpi, 2015). HCV belongs to the
Flaviviridae family and contains a 9.6 kb single-stranded RNA of positive polarity as its genome.
Its genomic RNA is the only known viral mRNA and bears a single open reading frame (ORF)
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encoding for a large polyprotein, which after proteolytic
processing renders the mature viral proteins that participate in
genome replication and in the assembly of new virus particles
(Paul et al., 2014). Translation of HCV mRNA is promoted and
regulated by an internal ribosome entry site (IRES) element that
mediates the internal initiation of translation by supporting the
interaction of components that participate in protein synthesis
(Hellen and Pestova, 1999; Khawaja et al., 2015). Results from
in vitro experiments initially suggested that the first step in
the initiation of this viral mRNA involved the recruitment
of initiation factors eIF3, eIF2, eIF5, GTP, initiator tRNAiMet
and a 40S ribosomal subunit by HCV IRES, yielding a 43S
preinitiation complex (Pestova et al., 1998; Otto and Puglisi,
2004). Precise attachment of this complex at the initiation AUG
codon forms a 48S complex in a process that does not involve
eIF4F or the scanning of the 5′-UTR. The HCV mRNA has
the ability to interact directly with the 40S ribosomal subunit,
recruiting then eIF3 and the ternary complex. In this process, two
modules of the IRES region, domains II and III, are necessary
for the interaction with the small ribosomal subunit and eIF3
(Lukavsky, 2009; Khawaja et al., 2015; Yamamoto et al., 2015).
Also, interaction of the HCV mRNA with preinitiation complexes
bearing eIFs can take place, in a process that displaces eIF2,
but requires eIF1A and eIF3 (Jaafar et al., 2016). Subsequently,
the 60S ribosomal subunit interacts with this complex in a
process mediated by eIF5B, which induces the release of eIF3
and leads to the formation of the 80S initiation complex, ready
to start the elongation process. This mechanism of internal
initiation is in sharp contrast to the canonical initiation of cellular
capped mRNAs. In this latter instance, the initiation of protein
synthesis begins with the recognition of the cap structure by
the eIF4F complex, which contains eIF4E, the cap recognition
protein, eIF4G, a scaffolding protein, and eIF4A, which exhibits
helicase activity in an ATP-dependent manner (Topisirovic
et al., 2011). Once eIF4F is bound to the cap structure at the
5′ end of cellular mRNAs, the small 40S ribosomal subunit
bearing eIF3 and the ternary complex eIF2-Met-tRNAiMet-GTP
interact with the mRNA. In addition, other factors such as
eIF1, eIF1A, and eIF5 bind to the small ribosomal subunit
forming the 48S complex. Then, this complex scans the 5′-
UTR until the initiator AUG codon is encountered (Sonenberg
and Hinnebusch, 2009; Hinnebusch et al., 2016). Joining of
the 60S ribosomal subunit is promoted by eIF5B concomitant
with the release of the eIFs in a GTP-dependent manner. Aside
from the requirement of only a few eIFs for the translation
of HCV mRNA, a number of IRES trans-acting factors, which
modulate HCV mRNA translation have been reported. These
factors include NSAP1, La protein, hnRNP L and D, Gemin5,
LSm1-7, IMP-1 and PCBP2; although their exact mechanism
of action in the translation of this viral mRNA remains largely
unknown (Niepmann, 2013).
The participation of eIF2 in the initiation of HCV mRNA
translation is controversial. In principle, two different
mechanisms can be followed: translation of HCV mRNA
takes place with eIF2 when this factor is active under normal
conditions; yet, IRES-driven translation occurs after inactivation
of this factor by phosphorylation under stress conditions. Initial
studies using reconstituted translation systems indicated that
eIF2 was necessary for the translation of this viral mRNA in vitro
(Pestova et al., 1998; Hellen and Pestova, 1999). Moreover,
analyses using mRNAs bearing HCV IRES in cell free systems
revealed the presence of eIF2 in the initiation complexes (Otto
and Puglisi, 2004). However, the interaction of this viral IRES
with preinitiation complexes displaces eIF2 from them (Jaafar
et al., 2016). That said, a novel class of inhibitors of the formation
of the ternary complex had no effect on HCV IRES-driven
translation, whereas these compounds potently interfered with
canonical protein synthesis (Robert et al., 2006). In addition,
stress conditions that promote the phosphorylation of eIF2α
and block cellular protein synthesis did not compromise HCV
mRNA translation (Terenin et al., 2008; Kim et al., 2011; Dabo
and Meurs, 2012; Jaafar et al., 2016). In light of this, several
candidates have been put forward to replace eIF2 for protein
synthesis promoted by HCV IRES under stress conditions. For
example, eIF5B can substitute for eIF2 in vitro in the delivery
of Met-tRNAiMet to small ribosomal subunits directed by HCV
mRNA (Terenin et al., 2008). Under these conditions, the
initiation of protein synthesis by HCV mRNA only requires two
initiation factors: eIF3 and eIF5B. Another proposal suggested
that eIF2D can substitute for eIF2 when this factor is inactivated
(Dmitriev et al., 2010; Skabkin et al., 2010). However, the
possibility that eIF5B or eIF2D participate in the initiation of
HCV mRNA in intact cells under stress conditions was not
analyzed, and only in vitro observations were reported. The
involvement of eIF2A for the translation of HCV mRNA in
place of eIF2 in intact cells and in cell free systems, has also
been proposed (Kim et al., 2011). Accordingly, Huh-7 cells
depleted for eIF2A cannot translate luciferase driven by the HCV
IRES in a bicistronic mRNA when eIF2α is phosphorylated.
In contrast to these findings, recent results have shown that
depletion of eIF2A or eIF2D or both factors in Huh-7 cells have
no effect for the translation of HCV mRNA (Jaafar et al., 2016).
Under stress conditions, only eIF1A, eIF5B, and eIF3 should be
necessary to direct the synthesis of proteins by this viral mRNA.
It has been speculated that under conditions in which eIF2 is
non-functional, the initiator Met-tRNAiMet can bind directly
to the ribosome following a mechanism that does not require
the ternary complex, but is directed by HCV IRES (Jaafar et al.,
2016).
Although eIF2A and eIF2D can form a complex with
Met-tRNAiMet and deliver it to 40S or 80S ribosomes, their
involvement in translation remains obscure. Indeed, early results
demonstrated that eIF2A can interact with Met-tRNAiMet and
deliver it to the ribosome (Merrick and Anderson, 1975).
However, this binding was much less efficient than that observed
using genuine eIF2 on artificial templates and eIF2A was unable
to promote the binding of Met-tRNAiMet to globin mRNA
(Adams et al., 1975). Moreover, a complex between Met-
tRNAiMet and eIF2D is formed in a GTP-independent fashion,
which can interact with the 40S ribosomal subunit to deliver
the initiator to the P site of the ribosome (Dmitriev et al.,
2010). eIF2D could displace deacylated tRNA and mRNA from
recycled 40S ribosomal subunits, and was also able to interfere
with the formation of the 48S initiation complex promoted
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by eIF2 (Skabkin et al., 2010). Both eIF2A and eIF2D are
65 kDa proteins. Deletion of the yeast ortholog of eIF2A or
eIF2D has no effect on cell viability (Zoll et al., 2002; Dmitriev
et al., 2010). Consistent with these observations, human cells
depleted for the genes encoding these two initiation factors
are also viable and global protein synthesis is unaffected (Sanz
et al., 2017). Results from mammalian cells have suggested
that eIF2A is involved in the translation of specialized cellular
mRNAs that initiate translation with non-AUG codons (Liang
et al., 2014; Starck et al., 2016). Elegant studies have recently
implicated eIF2A in cancer progression because it is involved in
the initiation of translation of upstream ORFs (Sendoel et al.,
2017). However, mice deleted for the eIF2A gene are completely
normal, supporting the concept that eIF2A is not necessary for
the translation of both normal and specialized cellular mRNAs
(Golovko et al., 2016).
Here, we examined the involvement of several eIFs in HCV
IRES-driven translation in human cells. Our findings indicate
that knock out human cells for eIF2A, eIF2D, or both, are not
only viable, but also synthesize proteins in a manner similar
to that of wild-type cells. In addition, by investigating the
potential involvement of these two proteins for the translation
of HCV mRNA, we demonstrate that these factors are not
required for translation of this viral mRNA, even when eIF2α is
phosphorylated.
MATERIALS AND METHODS
Cell Lines
Huh-7 cells are a well differentiated hepatocyte-derived cellular
carcinoma cell line established by Nakabayashi et al. (1982).
Cells were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM, Thermo Fisher Scientific, Waltham, MA, United States)
supplemented with non-essential amino acids, 4 µM glutamine,
10% fetal calf serum, 50 U mL−1 penicillin and 50 U mL−1
streptomycin.
Wild-type (WT) HAP1 human near-haploid cells and
knock-out HAP1 cells for eIF2A (cat# HZGHC002650c001),
eIF2D (cat# HZGHC002652c005) or double knock-cells
(cat# HZGHC005122c010) were purchased from Horizon
Discovery Group plc (Cambridge, United Kingdom). The
eIF2A knockout (KO) cell line (gi|977380191|ref|NM_032025.4|)
has a 16 bp deletion in exon 4 resulting in a frameshift
that generates a protein of 108 amino acids in place of the
original protein of 585 amino acids. The eIF2D KO cell line
(gi|56699484|ref|NM_006893.2|) has a 10 bp deletion in exon 3
resulting in a frameshift that generates a protein of 103 amino
acids in place of the original protein of 584 amino acids. The
double KO line has the same 16 bp deletion in exon 4 of the single
eIF2A KO cell line and a 22 bp deletion in exon 3 of eIF2D that
generates a protein of 99 amino acids in place of the 584 amino
acid protein. Cells were cultured in Iscove’s Modified Dulbecco’s
Medium (IMDM, Invitrogen, Carlsbad, CA, United States)
supplemented with 10% fetal calf serum.
All cell lines were maintained at 37◦C with 95% humidity and
5% CO2.
Plasmids and Reporter Constructs
The pT7HCV33core-Luc vector was kindly donated by
Dr. Takashi Shimoike (National Institute of Infectious Diseases,
Musashimurayama, Tokyo). It contains nucleotides 1–374 of the
HCV genome followed by the firefly luciferase gene and finally
the 3′ UTR of HCV. The construct is transcribed from a T7
polymerase promoter that precedes these sequences (Shimoike
et al., 2009). The gene segments from HCV comprise the
5′ UTR containing the IRES, followed by the first 33 nucleotides
of the HCV Core protein encoding a sequence that has previously
been shown to be crucial for the proper function of the IRES
(Reynolds et al., 1995). HCV-Luc RNA was in vitro transcribed
from pT7HCV33core-Luc.
The pTM1-Luc vector was derived from pTM1 (Moss et al.,
1990), and was constructed as described (Sanz et al., 2010).
It contains a modified form of the encephalomyocarditis virus
(EMCV) IRES along with the firefly luciferase gene. EMCV-Luc
RNA was in vitro transcribed from pTM1-Luc.
The pT7-RLuc-1EMCV-IGR-FLuc vector has been previously
described (Redondo et al., 2011). It contains the T7 promoter
followed by the Renilla luciferase gene and a deactivated form
of the EMCV IRES; it also contains the intergenic region of
cricket paralysis virus (CrPV) followed by the firefly luciferase
gene. CrPV-Luc RNA was in vitro transcribed from pT7-RLuc-
1EMCV-IGR-FLuc.
The β-globin construct contains the leader sequence from
the human β-globin gene followed by the firefly luciferase
gene. A Cap.βGlobin-Luc transcript was obtained by in vitro
transcription using pKS-GL-FL as a template, as described
by Castello et al. (2009). This plasmid was kindly provided
by Dr. Matthias Hentze and Dr. Francesca Moretti (EMBL,
Heidelberg, Germany).
The pFKi389LucNS3-3_dg_JFH vector, which was kindly
donated by Dr. Ralph Bartenschlager (Department of Molecular
Virology, University of Heidelberg, Heidelberg, Germany), was
used to obtain rep HCV-Luc RNA by in vitro transcription.
This plasmid contains the T7 promoter sequence fused to
nucleotides 1–389 of the JFH-1 consensus sequence, followed
by the firefly luciferase gene, the EMCV IRES, the NS3-to-NS5B
coding sequence, the 3′ NTR of JFH-1, the hepatitis delta virus
genomic ribozyme (dg), and the T7 terminator sequence (Schaller
et al., 2007). All plasmids contain the ampicillin resistance gene
for selection purposes.
In Vitro Transcription
Plasmids were linearized with the appropriate restriction
enzymes (pT7HCV33core-Luc: BamHI, pT7-RLuc-1EMCV-
IGR-FLuc: BamHI, pTM1-Luc: XhoI, pKS-GL-FL: HindIII;
pFKi389LucNS3-3_dg_JFH: MluI). All restriction enzymes
were purchased from New England Biolabs (Ipswich, MA,
United States). Linearized plasmids were used as templates for
in vitro RNA transcription using T7 or T3 RNA polymerases
(New England Biolabs, Ipswich, MA, United States), the
m7G(5′)ppp(5′)G cap analog (New England Biolabs) was used
for Cap.βGlobin-Luc transcription. Mixtures were incubated
for 2 h at 37◦C. In vitro-synthesized RNAs were treated with
recombinant DNase I (RNase-free) (Takara Bio USA Inc., Terra
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Bella, CA, United States) for 30 min at 37◦C. All transcripts
were transfected using Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA, United States) following the manufacturer
recommendations.
Inhibitors
Pateamine A [purified as described (Bordeleau et al., 2005)] and
hippuristanol (Bordeleau et al., 2006b) were kindly provided
by J. Pelletier (McGill University, Montreal, QC, Canada).
Sodium arsenite was obtained from Riedel-de Haën (Hanover,
Germany), and thapsigargin, tunicamycin, salubrinal, and
cycloheximide were purchased from Sigma–Aldrich (St. Louis,
MO, United States). Inhibitors are described in Table 1.
Luciferase Activity Assay
Cells were lysed in a buffer containing 0.5% Triton X-100,
25 mM glycylglycine pH 7.8, 1 mM dithiothreitol and complete
EDTA-free protease inhibitor cocktail (Roche Molecular Systems
Inc., Pleasanton, CA, United States) at the concentration
indicated by the supplier. Luciferase activity was determined
using the Luciferase Assay System (Promega, Madison, WI,
United States) and a Sirius Luminometer (Titertek-Berthold,
Pforzheim, Germany).
As a control, cycloheximide (CHX) was added to block
translation, in order to determine the luciferase synthesized in the
absence of compounds during the 1st hour of transfection.
Antibodies
Goat polyclonal anti-TIA-1 (C-20) (catalog number sc-17519),
rabbit polyclonal anti-eIF2α (catalog number sc-11386),
mouse monoclonal anti-eIF2α (catalog number sc-133132),
goat polyclonal anti-eIF3 (catalog number sc-16376), mouse
monoclonal anti-eIF4A (catalog number sc-14211), goat
polyclonal anti-eIF1 (catalog number sc-390122) antibodies
were purchased from Santa Cruz Biotechnology (Dallas, TX,
United States). Rabbit monoclonal anti-eIF1A antibody (catalog
number ab172623) was purchased from Abcam (Cambridge,
United Kingdom). Rabbit polyclonal anti-eIF2D antibody
(catalog number 12840-1-AP) was purchased from Proteintech
Group, Inc. (Rosemont, IL, United States). Rabbit polyclonal
anti-eIF2A antibody (catalog number A301-949A-M) was
purchased from Bethyl Laboratories Inc. (Montgomery, TX,
TABLE 1 | eIF2 inhibitors utilized in this study and the mechanisms by which they
increase eIF2α phosphorylation.
Inhibitor Mechanism of action
Sodium arsenite Induces phosphorylation of elF2α by activating
heme-regulated inhibitor kinase, a member of the
elF2α-specific kinase subfamily.
Thapsigargin Triggers the release of calcium to the cytoplasm from
the endoplasmic reticulum, activating PERK which in
turn phosphorylates elF2.
Tunicamycin Inhibits protein glycosylation and leads to endoplasmic
stress.
Salubrinal Inhibits the PP1/GADD34 complex which is known to
dephosphorylate elF2α.
United States). Rabbit polyclonal anti-phospho-eIF2α (serine
51) antibody (catalog number 9721) was purchased from Cell
Signaling Technology Inc. (Danvers, MA, United States). Rabbit
polyclonal antibody anti-eIF4GI has been obtained as previously
described (Aldabe and Carrasco, 1995).
Anti-rabbit immunoglobulin G antibody coupled to
peroxidase was purchased from Amersham (catalog number
NA934V) (GE Healthcare, Chicago, IL, United States). Specific
antibodies conjugated to Alexa 488 or Alexa 555 (A-21202 and
A-21432, respectively) were obtained from Invitrogen (Carlsbad,
CA, United States).
Immunocytochemistry and Confocal
Microscopy
Fixation, permeabilization and confocal microscopy were
performed as described by Madan et al. (2008) using the LSM
710 confocal laser scanning and multiphoton microscope
coupled to an inverted microscope (Axio Observer, Zeiss,
Oberkochen, Germany). Bound primary antibodies were
detected by secondary antibodies coupled to Alexa 488 or Alexa
555 (Molecular Probes Inc., Eugene, OR, United States). Nuclei
were stained with DAPI (4′-6-diamidino-2-phenylindole). All
images were collected and analyzed using Zeiss ZEN 2010
software.
Western Blotting
Cells were collected in sample buffer, boiled for 5 min
and processed by SDS-PAGE. After electrophoresis, proteins
were transferred to nitrocellulose membranes. Specific rabbit
polyclonal antibodies raised against phospho-eIF2α (Ser 51), total
eIF2α, eIF2A, and eIF2D were used at 1:1000 dilution in TBS
with 3% bovine serum albumin and 0.1% Tween 20. Anti-rabbit
immunoglobulin G antibody coupled to peroxidase (Amersham
GE Healthcare, Chicago, IL, United States) was used as secondary
antibody at a 1:5000 dilution. Protein bands were visualized with
the ECL detection system (Amersham, GE Healthcare).
Statistical Analysis
Data analysis was performed using Excel (Microsoft, Redmond,
WA, United States) and GraphPad Prism 6 (GraphPad Software
Inc., La Jolla, CA, United States) softwares. Data are shown
as mean with standard error. Statistical validation was done
using two-way analysis of variance (ANOVA) followed by a
Bonferroni post hoc test or one-way ANOVA with Tukey’s post
hoc test. Statistical significance is shown as: ∗p< 0.05, ∗∗p< 0.01,
∗∗∗p< 0.001.
RESULTS
HCV IRES-Driven Translation Is
Refractory to Inhibitors That Induce the
Phosphorylation of eIF2α in Human
Hepatic Cells
We sought to investigate the behavior of HCV IRES regarding
its dependence on several eIFs under appropriate physiological
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conditions. To accomplish this, we used the Huh-7 human
hepatoma cell line. We first tested a monocistronic mRNA
encoding for luciferase, bearing the HCV IRES at the 5′ end and
containing the 3′-UTR of this RNA (HCV-Luc). The presence
of the 3′-UTR is important because it is involved in modulating
translation of HCV mRNA (Ito et al., 1998; Bai et al., 2013;
Shwetha et al., 2015). To reproduce conditions similar to those
found during HCV infection, we also tested a replicon of HCV
(rep HCV-Luc), which contains the firefly luciferase gene, the
EMCV IRES, the NS3-to-NS5B coding sequence, the 3′ NTR
of JFH-1 and the hepatitis delta virus genomic ribozyme (dg)
(Schaller et al., 2007). As controls, we employed an mRNA
bearing the CrPV intergenic region (IGR) (CrPV-Luc), which
does not require eIFs to initiate protein synthesis (Jan and
Sarnow, 2002; Fernandez et al., 2014). We also employed the
IRES of EMCV (EMCV-Luc), which uses eIF2 and eIF4A for
translation (Welnowska et al., 2011), and a capped mRNA
containing the globin 5′-leader sequence (Cap.βGlo-Luc), which
follows the canonical mechanism for its translation. All these
mRNAs encode luciferase as a reporter gene (Supplementary
Figure 1).
Initially, we explored the action of different concentrations
of several compounds that induce the phosphorylation of
eIF2α. Accordingly, Huh-7 cells were first transfected with
HCV-Luc and EMCV-Luc mRNAs for 1 h and the following
compunds were added to the culture medium for a further
2 h: sodium arsenite (ARS), thapsigargin (TG), tunicamycin
(TM), and salubrinal (SAL). The first three compounds
activate kinases that induce eIF2α phosphorylation, whereas
SAL inhibits eIF2α dephosphorylation (Boyce et al., 2005;
Sanz et al., 2009; Vaughn et al., 2014; Garcia-Moreno et al.,
2015). As a control, cycloheximide (CHX) was added to
block translation, in order to determine the luciferase
synthesized in the absence of compounds during the 1st
hour of transfection. The four compounds tested blocked
luciferase synthesis directed by EMCV IRES in a concentration-
dependent manner, albeit to different extents and with different
inhibitory concentrations (Figure 1A). By contrast, the same
compounds exerted a stimulatory effect on HCV-Luc mRNA
translation. Among the compounds, ARS and TG were the
most potent inhibitors/stimulators. Accordingly, 100 µM
ARS almost entirely inhibited EMCV-Luc translation and
stimulated HCV-Luc translation by ∼250%. A similar result
was obtained with 2 µM TG. TM also stimulated luciferase
production from HCV-Luc ∼200% at 10 µg mL−1, but the same
concentration inhibited EMCV-Luc translation by only 30%.
Higher concentrations of this compound further decreased the
translation of EMCV-Luc, whereas the translation of HCV-Luc
was partially inhibited. Perhaps this inhibition is due to the
toxicity of TM at these high concentrations. A moderate
inhibition of luciferase activity from EMCV-Luc was observed
with SAL up to 200 µM (∼40%), and activity was completely
inhibited at 400 µM. Conversely, the activity of HCV-Luc was
stimulated ∼150–175% or remained unaltered in relation to the
control.
To assess whether the compounds induced the
phosphorylation of eIF2α, we performed western blotting
on cell extracts using specific antibodies. A robust increase
in eIF2α phosphorylation in Huh-7 cells was found with
the four agents assayed, with the most potent being ARS
(Figure 1B). We next tested the activity of the two most
potent inhibitors, ARS and TG, on four different mRNAs:
HCV-Luc, EMCV-Luc, CrPV-Luc, and Cap.βGlo-Luc. Two
concentrations of the inhibitors were added 1 h after transfection
of the different mRNAs, and CHX was also added as a
control as before. We found that protein synthesis directed
by both EMCV-Luc and Cap.βGlo-Luc was effectively blocked
by both compounds (Figure 1C). Notably, HCV-Luc was
stimulated by ARS and TG ∼150%. A comparable response
was also found with CrPV-Luc mRNA, albeit with a stronger
stimulation, overall indicating a similar behavior of both
mRNAs in the presence of these inhibitors as regards to their
dependence on eIF2. This stimulation of HCV and CrPV
IRESs is probably due to the inhibition of global cellular
translation by these compounds, thus reducing cellular mRNA
competition.
The translation driven by rep HCV-Luc mRNA in the
presence of ARS was also tested. To do this, Huh-7 cells
were transfected with rep HCV-Luc mRNA for 1 h, and
subsequently different concentrations of ARS were added to
the culture medium for a further 2 h. The luciferase synthesis
directed by rep HCV-Luc was stimulated ∼158% by treatment
with 50 µM ARS (Figure 1D), which is in good agreement
with the results obtained with HCV-Luc, suggesting that HCV
does not require eIF2 for its translation under replication
conditions. Curiously, ARS concentrations above 200 µM were
inhibitory for rep HCV translation. This result suggests that
some differences exist between the translation of the HCV-Luc
mRNA and the rep HCV, which bears most of the viral coding
sequences.
Requirement of eIF4A for IRES-Driven
Translation
Two natural compounds of marine origin, hippuristanol (Hipp)
and pateamine A (Pat A), have been characterized as potent
blockers of eIF4A activity (Bordeleau et al., 2006a; Low et al.,
2007). eIF4A is the helicase subunit of the eIF4F complex,
which additionally contains eIF4E and eIF4G (Topisirovic
et al., 2011). Both inhibitors have been shown to exhibit a
dual inhibitory effect on some viral mRNAs (Garcia-Moreno
et al., 2013; Gonzalez-Almela et al., 2015). To analyze the
action of Hipp and Pat A on luciferase synthesis driven
by the HCV, EMCV and CrPV IRES elements, different
concentrations of these compounds were added 1 h after
transfection for a further 2 h. Consistent with previous works
(Garcia-Moreno et al., 2013; Gonzalez-Almela et al., 2015),
both Hipp and Pat A potently blocked EMCV IRES-dependent
luciferase synthesis in human hepatic cells. By contrast, both
compounds had no detrimental effect on translation driven
by HCV or CrPV IRESs in these cells, and in fact strongly
stimulated translation (Figure 2). These results are consistent
with the concept that eIF4F does not participate in protein
synthesis directed by HCV IRES (Hellen, 2009; Niepmann,
2013).
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FIGURE 1 | Translation from the HCV IRES in Huh-7 cells is resistant to the action of eIF2 inhibitors. (A) Translation from the IRES of HCV or EMCV as measured by
luciferase activity in response to eIF2 inhibitor treatment in Huh-7 cells. Cells were transfected with in vitro synthesized HCV-Luc or EMCV-Luc mRNAs for 1 h and
then incubated with either cycloheximide CHX (5 µg mL−1) or ARS, TG, SAL, or TM for a further 2 h. Percentage change is relative to that in the non-treated control
(inhibitor concentration = 0). The readings from CHX treatments were subtracted from all as a baseline. Error bars represent the standard error of the mean, n = 3.
(B) Inhibitor treatment induces eIF2 phosphorylation in Huh-7 cells. Cells were transfected with in vitro synthesized HCV-Luc RNA as above and then treated or not
(Continued)
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FIGURE 1 | Continued
with ARS (100 µM), TG (5 µM), TM (40 µg mL−1), or SAL (200 µM) for 2 h. Proteins were resolved by SDS-PAGE and blots were probed with antibodies against
phospho-eIF2α and total eIF2α. Shown is a representative blot from three independent experiments. The phosphorylation of eIF2α induction rate was evaluated by
normalizing the raw value of P-eIF2α to that of total eIF2α as shown in the bar graph. (C) Huh-7 cells were transfected with different in vitro transcribed reporter
RNAs: HCV-Luc, EMCV-Luc, CrPV-Luc or Cap.βGlobin-Luc. After 1 h of transfection, cells were treated or not with ARS or TG, or with CHX, after which luciferase
activity was measured. Bars represent the relative luciferase activity with non-treated control (inhibitor concentration = 0) set as 100%. The readings from CHX
treatments were subtracted from all as a baseline. Error bars represent the standard error of the mean, n = 3. (A,C) Statistical significance of the differences between
treated samples compared to control was calculated with two-way ANOVA and a Bonferroni post hoc test, and is shown as: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
(D) Huh-7 cells were transfected with in vitro synthesized rep HCV-Luc mRNA. After 1 h of transfection, cells were treated with different concentrations of ARS or
CHX (5 µg mL−1) for 2 h, after which luciferase activity was measured. Bars represent the relative luciferase activity with non-treated control (inhibitor
concentration = 0) set as 100%. The readings from CHX treatments were subtracted as a baseline. Error bars represent the standard error of the mean, n = 3.
Statistical significance of the differences between treated samples compared to control was calculated with one-way ANOVA and a Tukey’s post hoc test, and is
shown as: ∗p < 0.05, ∗∗∗p < 0.001.
FIGURE 2 | Translation from the HCV IRES in Huh-7 cells is resistant to the action of eIF4A inhibitors. Huh-7 cells were transfected with reporter RNAs (HCV-Luc,
EMCV-Luc, or CrPV-Luc) for 1 h and then treated with either Hipp (0.2 and 0.4 µM) or Pat A (0.2 and 0.4 µM) for 2 h, after which luciferase activity was measured.
Bars represent the relative luciferase activity with non-treated control (inhibitor concentration = 0) set as 100%. The readings from CHX treatments were subtracted
from all as a baseline. Error bars represent the standard error of the mean, n = 3. Statistical significance of the differences between treated samples compared to
control was calculated with two-way ANOVA and a Bonferroni post hoc test, and is shown as: ∗∗p < 0.01, ∗∗∗p < 0.001.
Cellular Localization of eIFs Treated with
Sodium Arsenite or Pateamine A
It is well established that ARS and Pat A induce the formation
of cytoplasmic stress granules (SGs). The molecular mechanism
of this induction is different for each compound: ARS induces
eIF2α phosphorylation, whereas SG formation by Pat A occurs
via a mechanism independent of this process (Dang et al., 2006;
Linero et al., 2011). A number of components of the translation
machinery, including preinitiation complexes containing 40S
ribosomal subunits, are present in SGs (Kedersha and Anderson,
2009; Anderson et al., 2015; Penas et al., 2016). It was of note that
HCV-Luc mRNA was efficiently translated even in the presumed
presence of SGs (Figures 1, 2). Curiously, HCV infection of
Huh-7 cells leads to a dynamic oscillation in the formation of SGs
(Ruggieri et al., 2012; Valadao et al., 2016).
To survey the action of ARS and Pat A on SG formation and
to examine the localization of different eIFs, Huh-7 cells were
transfected with HCV-Luc, incubated with ARS and Pat A for
2 h, and then processed for immunocytochemistry. We initially
examined the localization of eIF4G together with TIA-1, eIF3 or
eIF4A. As illustrated in Figure 3A, eIF4G (stained green) was
mostly located in the cytoplasm in Huh-7 control cells, whereas
TIA-1 (stained red) was predominantly nuclear. Transfection
with HCV-Luc RNA led to the appearance of a few SGs in
Huh-7 cells containing both eIF4G and TIA-1. Treatment of
transfected cells with ARS or Pat A greatly increased the number
and size of SGs containing TIA-1 and eIF4G (Figure 3A). eIF3
(stained red) commonly showed a granular and cytoplasmic
location. Furthermore, transfection with HCV-Luc RNA led
to the formation of some granules with concentrated eIF4G,
presumably SGs, without co-localization of eIF3. However, ARS
treatment robustly modified eIF3 distribution, which showed
a more compacted perinuclear location without co-localization
of eIF4G. This effect was not seen after Pat A treatment
(Figures 3A,B). Moreover, whereas eIF4A (stained red) displayed
a cytoplasmic location with a homogeneous dispersion in control
cells, it was clearly present in small SGs coincident with eIF4G
(stained green) in HCV-Luc transfected cells, which were larger
after treatment with ARS or Pat A (Figure 3A). The finding that
eIF4G is present in SGs suggests that it is not participating in
the translation of HCV-Luc mRNA. This is also in agreement
with the lack of inhibition when eIF4A is blocked by Hipp or
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FIGURE 3 | Analysis of stress granule formation in Huh-7 cells transfected with in vitro synthesized HCV-Luc RNA and treated with sodium arsenite or pateamine A.
Cells were seeded on microscope cover slips, transfected with HCV-Luc mRNA for 1 h and then treated with either ARS (200 µM) or Pat A (0.4 µM) for 2 h. Control
cells underwent the transfection procedure without RNA. After treatments, cells were permeabilized for immunocytochemistry. (A) Shows staining with primary rabbit
anti-eIF4G antibody (green) together with primary goat anti-TIA-1, goat anti-eIF3 or mouse anti-eIF4A antibodies (red). (B) Shows staining with primary rabbit
anti-eIF2 antibody (green) together with primary goat anti-TIA-1 or goat anti-eIF3 antibodies (red). Anti-goat antibodies conjugated to Alexa 555 were used to detect
TIA-1 or eIF3 (red), anti-mouse antibody conjugated to Alexa 555 was used to detect eIF4A (red), anti-rabbit antibodies conjugated to Alexa 448 were employed to
detect eIF4G or eIF2 (green). DAPI was used to stain the nuclei (blue). Scale bar, 20 µm.
Pat A, suggesting that the eIF4F complex is not involved in
HCV mRNA translation. We also considered it of interest to
analyze other factors of the translation machinery (Figure 3B).
eIF2 (stained green) had a dispersed cytoplasmic localization in
control and transfected cells with or without ARS treatment,
whereas in transfected cells treated with Pat A eIF2 appeared in
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FIGURE 4 | Thapsigargin, tunicamycin or salubrinal treatment induces stress granule formation in transfected Huh-7 cells. (A) Cells were seeded on microscope
cover slips and transfected with different reporter RNAs: HCV-Luc, EMCV-Luc, CrPV-Luc or Cap.βGlobin-Luc. After 1 h of transfection, cells were incubated in
DMEM medium for 2 h. (B) Cells were seeded on microscope cover slips and transfected with HCV-Luc. After 1 h of transfection, cells were treated with various
eIF2 inhibitors (TG, TM, or SAL) for 2 h. In both cases, after treatments cells were permeabilized for immunocytochemistry using primary goat anti-TIA-1 and rabbit
anti-eIF4G antibodies. An anti-goat antibody conjugated to Alexa 555 was used to detect TIA-1 (red) and an anti-rabbit antibody conjugated to Alexa 448 was
employed to detect eIF4G (green). DAPI was used to stain the nuclei (blue). Scale bar, 20 µm.
SGs coincident with TIA-1 (stained red) (Figure 3B). Curiously,
Pat A not only blocked the action of eIF4A, but also induced
the sequestration of eIF2 into SG granules. Finally, as shown in
Supplementary Figure 2, no change in the localization pattern
of eIF1A was found after RNA transfection with or without
treatment with ARS or Pat A. Therefore, eIF1A is not sequestered
into SGs. This is consistent with the idea that eIF1A may
participate in the translation of HCV mRNA (Jaafar et al.,
2016). In conclusion, eIF4G and eIF4A, which are located in
SG, are not involved in HCV mRNA translation, whereas eIF3
and eIF1A, which are present in the cytosol, could be engage
in the initiation of this translation. In the case of eIF2, it
is located in SG after phosphorylation by Pat A, consistent
with the concept that it does not participate in HCV IRES
translation.
We next addressed whether transfection with other RNAs
could also induce the formation of SGs. We transfected Huh-7
cells with HCV-Luc (as a control), EMCV-Luc, CrPV-Luc
or Cap.βGlobin-Luc RNAs for 1 h followed by incubation
in DMEM for 2 h before immunocytochemistry analysis.
Interestingly, the transfection with these RNAs also induced
the formation of a few small granules (Figure 4A). This
represent an interesting aspect to take into consideration,
since not only HCV-Luc RNA but also transfection with
other RNAs may induce this response. Of interest, treatment
with TG, TM or SAL also increased the formation of large
quantities of SGs in cells transfected with HCV-Luc mRNA
as shown by staining for eIF4G (green) and TIA-1 (red)
(Figure 4B).
Translation of mRNA Bearing HCV IRES
in Knock-out Human Cells Depleted for
eIF2A, eIF2D, or Both Factors
Several studies have suggested that eIF2 can be replaced
with other cellular proteins under stress conditions (Terenin
et al., 2008; Dmitriev et al., 2010; Skabkin et al., 2010; Kim
et al., 2011). Accordingly, the possibility that eIF2A or eIF2D
participate in the initiation of translation of HCV mRNA when
eIF2α is phosphorylated has been put forward. To test this
idea, we made use of human cells knocked out for eIF2A
(HAP1-eIF2A−), or eIF2D (HAP1-eIF2D−) or both (HAP1-
eIF2A−/2D−). We have recently shown that these cells are viable,
exhibit a normal morphology and have a similar synthesis of
global proteins to that of parental control cells (Sanz et al.,
2017).
First, we analyzed the activity of the different inhibitors
that induce the phosphorylation of eIF2α in WT HAP1 cells
transfected with different mRNAs. We followed a protocol
similar to that used for Huh-7 cells and each compound
was assayed at different concentrations. Consistent with the
results for hepatoma cells, the compounds differentially affected
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FIGURE 5 | Translation from the HCV IRES in HAP1 WT cells is resistant to the action of eIF2 inhibitors. (A) Translation from the IRES of HCV or EMCV as measured
by luciferase activity in response to eIF2 inhibitor treatment in HAP1 WT cells. Cells were transfected with HCV-Luc or EMCV-Luc mRNAs for 1 h and then incubated
with either CHX (5 µg mL−1) or ARS, TG, TM, or SAL for a further 2 h. Percentage change is relative to non-treated control (inhibitor concentration = 0). The
readings from CHX treatments were subtracted from all as a baseline. Error bars represent the standard error of the mean, n = 3. Statistical significance of the
differences between treated samples compared to control was calculated with two-way ANOVA and a Bonferroni post hoc test, and is shown as: ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001. (B) Inhibitor treatment induces eIF2α phosphorylation in HAP1 WT cells. Cells were transfected for 1 h and then treated or not with either
ARS (200 µM), TG (5 µM), TM (40 µg mL−1) or SAL (50 µM) for 2 h. Proteins were resolved using SDS-PAGE and then samples were probed with antibodies for
phospho-eIF2α and total eIF2α. Shown is a representative blot from three independent experiments. The phosphorylation of eIF2α induction rate was evaluated by
normalizing the raw value of P-eIF2α to that of total eIF2α as shown in the bar graph.
the translation directed by EMCV or HCV IRESs: whereas
translation driven by EMCV IRES was inhibited, HCV IRES-
dependent translation was stimulated by these compounds
(Figure 5A). As stated earlier, this stimulation can be due to
phosphorylation of eIF2α (Figure 5B), which blocks cellular
translation, and also to the sequestration of many cellular
mRNAs in SGs, impeding the competition for components of the
translational machinery.
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FIGURE 6 | Characterization of the different HAP1 cell lines by immunocytochemistry and western blotting. (A) HAP1 WT, HAP1-eIF2A−, HAP1-eIF2D−, and
HAP1-eIF2A−/eIF2D− cells were seeded on microscope coverslips, fixed and stained with primary rabbit polyclonal anti-eIF2A or anti-eIF2D antibodies and a mouse
monoclonal anti-eIF2α antibody. An anti-mouse antibody conjugated to Alexa 555 was used to detect eIF2α (red) and an anti-rabbit antibody conjugated to Alexa
488 was employed to detect eIF2A and eIF2D (green). DAPI was used to stain the nuclei (blue). Scale bar, 20 µm. (B) The presence of eIF2A or eIF2D in HAP1 WT,
HAP1-eIF2A−, HAP1-eIF2D−, and HAP1-eIF2A−/eIF2D− cells was also determined by western blotting with rabbit polyclonal anti-eIF2A and anti-eIF2D antibodies.
eIF2α was used as loading control for the four cell lines. Proteins were resolved by SDS-PAGE and samples were probed with antibodies to show the presence of
these factors in the HAP1 cells lines. Shown is a representative blot from three independent experiments.
To study the participation of eIF2A and eIF2D in the
translation of the mRNA reporter bearing HCV IRES, we
employed the KO cell lines indicated above. We first validated
the cell lines by immunohistochemistry and western blotting. The
subcellular localization of eIF2A and eIF2D in HAP1 WT, single
KO and double KO variants is shown in Figure 6. The expression
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FIGURE 7 | Resistance of HCV IRES translation to the eIF2 inhibitor sodium arsenite is independent of eIF2A and eIF2D. HAP1 cell lines WT, HAP1-eIF2A−,
HAP1-eIF2D−, and HAP1-eIF2A−/eIF2D− were transfected with reporter RNAs (HCV-Luc, EMCV-Luc, CrPV-Luc or Cap.βGlobin-Luc) for 1 h and treated with ARS
(200 µM) for 2 h. Bars represent the relative luciferase activity with non-treated control (inhibitor concentration = 0) set as 100%. The readings from CHX treatments
were subtracted from all as a baseline. Error bars represent the standard error of the mean, n = 3. Statistical significance of the differences between ARS treated
samples compared to control was calculated with two-way ANOVA and a Bonferroni post hoc test, and is shown as: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
of eIF2A and eIF2D was examined by immunocytochemistry
using specific antibodies. Double staining of HAP1 WT cells
revealed that eIF2A was clearly expressed in the cytoplasm and
a proportion was also found in the nucleus, whereas eIF2D
was mainly cytoplasmic. As expected, eIF2A was not detected
in HAP1-eIF2A− cells or HAP1 eIF2A−/eIF2D− (Figure 6A).
Similarly, eIF2D was not found in HAP1-eIF2D− cells or
HAP1 eIF2A−/eIF2D− (Figure 6A). Loss of eIF2A or eIF2D
in the respective KO cell lines was verified by western blotting
(Figure 6B).
The four cell lines, HAP1 WT, HAP1-eIF2A−, HAP1-eIF2D−,
and HAP1-eIF2A−/2D− were transfected with different mRNAs
encoding luciferase and treated or not with ARS to induce
eIF2α phosphorylation. Interestingly, the translation of the
different mRNAs was similar in all four cell lines analyzed, both
in the absence or presence of ARS (Figure 7). As expected,
luciferase synthesis from both control mRNAs, EMCV-Luc and
Cap.βGlo-Luc was strongly inhibited by ARS in all four cell lines.
By contrast, luciferase translation from CrPV-Luc mRNA was
stimulated by ARS treatment. Thus, HCV-Luc mRNA directed
the synthesis of luciferase in all four cell lines, even when ARS
was present and eIF2α was phosphorylated. This finding clearly
demonstrates that neither eIF2A nor eIF2D are involved in HCV-
Luc translation. Moreover, these two factors do not replace the
activity of eIF2 in IRES-driven translation when it is inactivated.
In the statistical analysis using two-way ANOVA, we have seen
that there is no statistical interaction between any of the four
HAP1 lines. That means that the effect of ARS is the same
in the four cell lines, although there are differences between
the levels of translation between them. The ARS increases in
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the same way the expression of Luc in the four lines tested
despite the absence of eIF2A and/or eIF2D. Therefore the level
of translation of HCV-Luc does not seem to depend on the
presence of these factors. In turn, we also see that there is a
significant difference between control cells and treated with ARS,
as indicated in Figure 7, therefore ARS effectively stimulates
the translation of HCV-Luc in the four HAP1 lines in a similar
degree. These findings are consistent with a recent report showing
that depleting Huh-7 cells of eIF2A, eIF2D or both with siRNAs
has no effect on luciferase synthesis promoted by HCV IRES
(Jaafar et al., 2016).
DISCUSSION
Animal viruses employ a variety of mechanisms to translate their
mRNAs (Firth and Brierley, 2012). The precise mechanisms of
viral mRNA translation remain the subject of intense research.
Some animal viruses utilize RNA components known as IRES
elements to direct the translation machinery to an internal
position at the 5′-UTR of the viral messenger (Hellen, 2009;
Plank and Kieft, 2012). However, the mechanism of IRES-driven
translation also can differ between the various animal viruses
that use this strategy. In the case of HCV, the exact mode
by which its mRNA initiates protein synthesis as regards to
participating eIFs is controversial. One school of thought is
that under normal cellular conditions, HCV mRNA initiates
translation using the ternary Met-tRNAiMet-eIF2-GTP complex,
whereas eIF2 is dispensable under stress conditions (Jaafar et al.,
2016). Yet, the possibility exists that eIF2 never participates in the
initiation of HCV mRNA in infected cells. Indeed, the interaction
of HCV IRES with the preinitiation complexes displaces eIF2
(Jaafar et al., 2016), and it is conceivable that the IRES element
itself is sufficient to initiate translation without eIF2, even when
this factor is active. Studies in vitro and experiments in culture
cells indicate that eIF2A can replace eIF2 in HCV IRES-directed
translation (Kim et al., 2011). Moreover, other studies point to
eIF2D as the responsible factor to initiate translation in place of
eIF2 (Dmitriev et al., 2010; Skabkin et al., 2010), based mainly
on in vitro observations. Our present findings in human cells
clearly demonstrate that neither eIF2A nor eIF2D are involved
in protein synthesis directed by HCV IRES, and are in accord
with a recent result demonstrating that knockdown of eIF2A or
eIF2D in hepatoma cells has little effect on HCV IRES-driven
translation (Jaafar et al., 2016). Therefore, the results obtained
using siRNAs by Jaafar et al. and our present findings with KO cell
lines are complementary and both demonstrate that those factors
do not participate in HCV translation. In addition, the possibility
that eIF2A can be replaced by eIF2D, or vice versa, is not
supported by the finding that in the double KO cell line HCV-Luc
mRNA is efficiently translated even under stress conditions in the
presence of ARS. Moreover, elegant studies directed to uncover
the cellular genes necessary for HCV replication and growth
failed to detect eIF2A or eIF2D (Marceau et al., 2016). Although
that study only examined cellular genes dispensable for human
HAP1 cells, it must be stressed that, as we have demonstrated,
neither eIF2A nor eIF2D are necessary for the viability of this
cell line (Sanz et al., 2017). Therefore, we can conclude that these
genes do not participate in the translation of this viral mRNA, and
they do not replace eIF2 even after the induction of cellular stress.
The use of KO cell lines will be helpful in future studies to unravel
the mode of initiation and the factors required to translate viral
mRNAs. Indeed, we believe that in vitro experiments that suggest
the requirement for some eIFs to translate a given mRNA should
be followed by in vivo experiments in culture cells and in this
respect KO cells will be useful tools. Remarkably, all eIFs could be
dispensable in in vitro translation of HCV at high concentrations
of magnesium ions (Lancaster et al., 2006). Thus, the modulation
of in vitro conditions strongly affects the requirements for eIFs in
the initiation of protein synthesis by HCV IRES.
There is more consensus about the lack of any involvement
of the three factors that form part of the eIF4F complex for
the initiation of protein synthesis directed by HCV mRNA
(Niepmann, 2013). Since this viral messenger does not have a
5′ cap structure, it seems logical that eIF4E is not involved in its
translation. Also, since there is no scanning mechanism during
the initiation event, eIF4A (the helicase enzyme involved in
scanning) does not participate in this process. There are currently
two compounds (Hipp and Pat A) from marine origin that are
selective inhibitors of eIF4A (Bordeleau et al., 2006a; Low et al.,
2007). Both are very useful to test the involvement of this factor in
the translation of any given mRNA. We show here that these two
agents do not affect luciferase synthesis driven by HCV IRES in
monocistronic mRNAs containing the HCV 3′-UTR in human
hepatic cells. Our results are in good agreement with previous
observations showing that these compounds do not block HCV
IRES-dependent translation in dicistronic mRNAs (Bordeleau
et al., 2006a; Low et al., 2007). This fact, together with the finding
that eIF4G are localized in SGs after ARS treatment, is consistent
with the idea that the eIF4F complex does not participate in the
initiation of translation of HCV mRNA.
Possibly the most important issue to be clarified in the
initiation of protein synthesis driven by HCV IRES is to
determine whether eIF2 is employed or not under normal
conditions. In vitro observations have demonstrated that the
HCV IRES can directly interact with native 40S ribosomal
subunits devoid of eIFs that, afterward, can recruit eIF3 and
the ternary complex containing eIF2 (Ji et al., 2004; Otto and
Puglisi, 2004). The interaction of the HCV IRES with 40S
or 80S ribosomes leads to the remodeling of its structure, in
such a way that domain II is bound to the tRNA exit site,
whereas domain III positions with the initiation codon at the
head of the small ribosomal subunit (Boehringer et al., 2005).
Fluorescently labeled 40S ribosomal subunits in the ribosomal
protein RPS25 irreversibly bind to HCV IRES, leading to
conformational rearrangements of domain II that are stabilized
by yet undefined cellular proteins (Fuchs et al., 2015). It is,
however, unclear if under physiological conditions in intact
cells HCV mRNA interacts with native 40S or more probably
with preinitiation complexes that would contain several eIFs,
including eIF3 and eIF1A (Jaafar et al., 2016). IRES binding to
preinitiation complexes in intact cells can displace eIF2 by the
interaction of domain II with the 40S subunit (Locker et al., 2007).
In fact, the binding sites of domain II and the ternary complex
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overlap in such a way that the interaction of both on the 40S
would clash (Jaafar et al., 2016). It is feasible that domain
II of HCV IRES functionally replaces the ternary complex,
without the necessity for other cellular factors such as eIF2A or
eIF2D even under normal cellular conditions. Indeed, domain
II adopts an L-shaped structure and interacts with the 40S
subunit in the head region of the E site, allowing the apical
loop of domain II to reach deeply into the mRNA cleft near
the coding RNA in the ribosomal P site (Spahn et al., 2001;
Lukavsky et al., 2003). Therefore, the IRES may be able to
replace the ternary complex and after the formation of the 80S
ribosome, the P site could be occupied, leaving the A site free
that could be positioned with the AUG initiation codon ready
to start translation. This model is akin to that described for
the functioning of CrPV IRES, with the exception that eIF3 is
involved in HCV translation (Jan and Sarnow, 2002; Fernandez
et al., 2014).
The exact functioning of eIF2A or eIF2D during cellular
mRNA translation remains to be elucidated. The recent
generation of an eIF2A knockout mouse clearly demonstrates
that this factor is not required during embryogenesis, nor
involved in the translation of tissue-specific mRNAs (Golovko
et al., 2016). The recent finding that eIF2A participates in
tumorigenesis makes the study of this factor particularly relevant
(Sendoel et al., 2017). Nonetheless, eIF2A is likely required
for additional functions besides its involvement in cancer
progression. The use of the human KO cell lines employed in
this work could help to improve our understanding of eIF2A and
eIF2D in translation. As observed recently (Sanz et al., 2017),
and in the present study, these two factors are not necessary for
global translation of cellular mRNAs and for luciferase synthesis
directed by HCV, EMCV, or CrPV IRESs. Future studies directed
to analyze the behavior of specialized cellular mRNAs in these
KO cell lines will help to ascertain the precise roles of eIF2A and
eIF2D.
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